MYLK and triple-negative breast carcinoma: In the present study, we demonstrated that TAZ knockdown inhibited the migration of highly invasive triple-negative breast cancer cells (MDA-MB-231) by reducing the protein abundance of RhoA and Rho-dependent kinases, particularly LIMK1 and MLCK.